This is a heavily interactive web application, and JavaScript is required. Simple HTML interfaces are possible, but that is not what this is.
Post
The Washington Post
washingtonpost.com
did:plc:k5nskatzhyxersjilvtnz4lh
Eli Lilly is ramping up its campaign against imitations of its blockbuster appetite-suppressing drugs, seeking to put an end to a regulatory designation that has allowed cheaper, off-brand versions to flourish.
https://www.washingtonpost.com/business/2024/08/30/mounjaro-zepbound-eli-lilly-weight-loss-drugs/
2024-08-30T17:25:21.276Z